[go: up one dir, main page]

MEP40008A - Kristalni monohidrat, postupak za njegovo pripremanje i njegova primjena za pripremanje lijeka - Google Patents

Kristalni monohidrat, postupak za njegovo pripremanje i njegova primjena za pripremanje lijeka

Info

Publication number
MEP40008A
MEP40008A MEP-400/08A MEP40008A MEP40008A ME P40008 A MEP40008 A ME P40008A ME P40008 A MEP40008 A ME P40008A ME P40008 A MEP40008 A ME P40008A
Authority
ME
Montenegro
Prior art keywords
medicament
producing
production
same
crystalline monohydrate
Prior art date
Application number
MEP-400/08A
Other languages
English (en)
Inventor
Rolf Banholzer
Peter Sieger
Christian Kulinna
Michael Trunk
Manfred Ludwig August Graulich
Peter Specht
Helmut Meissner
Andreas Mathes
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP40008(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP40008A publication Critical patent/MEP40008A/bs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pronalazak se odnosi na kristalni monohidrat (1α,2ß,4β,5α,7β)-7-[(hidroksi-2-tienilacetil)oksi]-9,9-dimetil-3-oksa-9-azoniatriciklo-[3.3.1.02,4]nonan-bromida, na postupak za njegovo pripremanje, kao i na njegovu primjenu za pripremanje lijekq, naročito za pripremanje lijeka sa antiholinergijskim dejstvom.
MEP-400/08A 2000-10-12 2001-09-28 Kristalni monohidrat, postupak za njegovo pripremanje i njegova primjena za pripremanje lijeka MEP40008A (bs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050621 2000-10-12
YU27303A RS50218B (sr) 2000-10-12 2001-09-28 Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje leka
PCT/EP2001/011225 WO2002030928A1 (de) 2000-10-12 2001-09-28 Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (1)

Publication Number Publication Date
MEP40008A true MEP40008A (bs) 2011-02-10

Family

ID=7659568

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-400/08A MEP40008A (bs) 2000-10-12 2001-09-28 Kristalni monohidrat, postupak za njegovo pripremanje i njegova primjena za pripremanje lijeka
MEP-2008-400A ME00243B (me) 2000-10-12 2001-09-28 Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje lijeka

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-400A ME00243B (me) 2000-10-12 2001-09-28 Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje lijeka

Country Status (46)

Country Link
EP (2) EP1326862B1 (bs)
JP (1) JP3764422B2 (bs)
KR (1) KR100823860B1 (bs)
CN (2) CN1221549C (bs)
AP (1) AP1572A (bs)
AR (2) AR034389A1 (bs)
AT (1) ATE276253T1 (bs)
AU (2) AU2002214996B2 (bs)
BG (1) BG66161B1 (bs)
BR (1) BR0114584A (bs)
CA (1) CA2425539C (bs)
CR (1) CR6938A (bs)
CZ (1) CZ301841B6 (bs)
DE (1) DE50103666D1 (bs)
DK (1) DK1326862T3 (bs)
DZ (1) DZ3478A1 (bs)
EA (1) EA004381B1 (bs)
EC (1) ECSP034540A (bs)
EE (1) EE04567B1 (bs)
EG (1) EG24142A (bs)
ES (1) ES2228965T3 (bs)
GE (1) GEP20063905B (bs)
HR (1) HRP20030276B1 (bs)
HU (1) HU226830B1 (bs)
IL (2) IL155335A0 (bs)
IS (1) IS2339B (bs)
MA (1) MA25842A1 (bs)
ME (2) MEP40008A (bs)
MX (1) MXPA03003221A (bs)
MY (1) MY126931A (bs)
NO (1) NO328465B1 (bs)
NZ (1) NZ525733A (bs)
OA (1) OA12403A (bs)
PE (1) PE20020422A1 (bs)
PL (1) PL207870B1 (bs)
PT (1) PT1326862E (bs)
RS (1) RS50218B (bs)
SA (1) SA01220412B1 (bs)
SI (1) SI1326862T1 (bs)
SK (1) SK287009B6 (bs)
TR (1) TR200402579T4 (bs)
TW (1) TW589313B (bs)
UA (1) UA74215C2 (bs)
UY (2) UY26962A1 (bs)
WO (1) WO2002030928A1 (bs)
ZA (1) ZA200302500B (bs)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159238A0 (en) * 2001-06-22 2004-06-01 Boehringer Ingelheim Pharma Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
RS20060292A (sr) * 2003-11-03 2008-08-07 Boehringer Ingelheim International Gmbh., Postupak za dobijanje novih soli tiotropijuma, nove soli tiotropijuma kao takve, kao i farmaceutske formulacije koje ih sadrže
EP2319844A1 (de) * 2003-11-03 2011-05-11 Boehringer Ingelheim International GmbH Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
RS20060291A (sr) * 2003-11-03 2008-06-05 Boehringer Ingelheim International Gmbh., Novi kristalni anhidrat sa antiholinergijskim dejstvom
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
NZ550797A (en) 2004-04-22 2010-08-27 Boehringer Ingelheim Int Pharmaceutical combinations containing 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethylethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one for treating respiratory diseases
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
MX2007004768A (es) * 2004-10-21 2007-05-10 Boehringer Ingelheim Int Blister para inhaladores.
WO2006094924A2 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
CN101163706A (zh) 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
MX2007012907A (es) 2005-04-28 2008-03-14 Boehringer Ingelheim Int Nuevos compuestos para el tratamiento de enfermedades inflamatorias.
EP1879888A2 (en) * 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Crystalline forms of tiotropium bromide
NZ563596A (en) 2005-05-02 2011-01-28 Boehringer Ingelheim Int Crystalline form of tiotropium bromide anhydrate
WO2006134021A2 (en) * 2005-06-15 2006-12-21 Boehringer Ingelheim International Gmbh Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
CA2617717C (en) * 2005-08-06 2014-02-11 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
DK1917253T3 (da) 2005-08-15 2015-03-30 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af betamimetika
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de) * 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
MX2007009988A (es) * 2005-12-19 2008-02-22 Sicor Inc Formas novedosas de bromuro de tiotropio y procesos para su preparacion.
CN101360744A (zh) * 2005-12-19 2009-02-04 西科尔公司 纯和稳定的噻托溴铵
AU2006334367B2 (en) * 2006-01-04 2012-11-08 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of moderate persistent asthma
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP2051714B1 (de) 2006-08-07 2011-04-13 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
EP2610258B1 (de) 2007-10-19 2014-08-27 Boehringer Ingelheim International Gmbh Substituierte Piperidino-Dihydrothienopyrimidine
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2010011813A1 (en) * 2008-07-23 2010-01-28 Alkermes, Inc. Complex of trospium and pharmaceutical compositions thereof
US20120053164A1 (en) 2008-12-19 2012-03-01 Boehringer Ingelheim International Gmbh Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
WO2010101538A2 (en) 2009-03-06 2010-09-10 Bilgic Mahmut New crystal forms
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
NZ597920A (en) 2009-08-07 2014-05-30 Generics Uk Ltd Anhydrate of tiotropium bromide
EP2513086B1 (en) 2009-12-17 2015-04-29 Boehringer Ingelheim International GmbH Novel antagonists for ccr2 and uses thereof
EP2513093B1 (en) 2009-12-17 2014-08-27 Boehringer Ingelheim International GmbH New ccr2 receptor antagonists and uses thereof
JP5629331B2 (ja) 2010-01-29 2014-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ナフチリジン及びｓｙｋキナーゼ阻害剤としてのその使用
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2571870B1 (en) 2010-05-17 2015-01-21 Boehringer Ingelheim International GmbH Ccr2 antagonists and uses thereof
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
EP2576538B1 (en) 2010-06-01 2015-10-28 Boehringer Ingelheim International GmbH New CCR2 antagonists
JP5959537B2 (ja) 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201102068A2 (tr) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
JP5786257B2 (ja) 2011-06-16 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の選択的ｃｃｒ２拮抗薬
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
JP5860960B2 (ja) 2011-07-26 2016-02-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換キノリン類及び医薬としてのそれらの使用
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
SI2914593T1 (sl) 2012-11-05 2017-05-31 Zentiva, K.S. Stabilizacija tiotropijevih solvatov
EP2913332A1 (en) * 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
ME03472B (me) 2014-03-19 2020-01-20 Boehringer Ingelheim Int Heteroarilni sik inhibitori
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
RU2567539C1 (ru) * 2015-02-04 2015-11-10 Индивидуальный предприниматель Михайлов Олег Ростиславович КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
EP3414243A1 (en) 2016-02-11 2018-12-19 Sima Patent Ve Lisanslama Hizmetleri Ltd. STI Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) * 2016-11-04 2018-05-11 Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇ A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG52459A1 (en) * 1992-12-09 1998-09-28 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
CA2338680C (en) * 1998-08-04 2008-10-14 Jago Research Ag Medicinal aerosol formulations

Also Published As

Publication number Publication date
BR0114584A (pt) 2003-08-26
CN100519558C (zh) 2009-07-29
IS6772A (is) 2003-04-09
GEP20063905B (en) 2006-08-25
PL366041A1 (en) 2005-01-24
KR20030042008A (ko) 2003-05-27
MXPA03003221A (es) 2004-12-03
PT1326862E (pt) 2004-11-30
HRP20030276A2 (en) 2005-02-28
HUP0301022A3 (en) 2005-12-28
ZA200302500B (en) 2004-04-22
ECSP034540A (es) 2003-07-25
NO328465B1 (no) 2010-02-22
AU1499602A (en) 2002-04-22
TW589313B (en) 2004-06-01
ME00243B (me) 2011-05-10
CN1469877A (zh) 2004-01-21
CA2425539A1 (en) 2003-04-11
CN1733761A (zh) 2006-02-15
MA25842A1 (fr) 2003-07-01
DK1326862T3 (da) 2004-11-22
UY34901A (es) 2015-02-27
AR034389A1 (es) 2004-02-25
UA74215C2 (uk) 2005-11-15
NO20031694D0 (no) 2003-04-11
SK287009B6 (sk) 2009-09-07
EA200300457A1 (ru) 2003-10-30
EP1326862A1 (de) 2003-07-16
CR6938A (es) 2004-10-28
SI1326862T1 (sl) 2005-02-28
EP1326862B1 (de) 2004-09-15
AR068527A2 (es) 2009-11-18
EG24142A (en) 2008-08-06
IL155335A0 (en) 2003-11-23
IL155335A (en) 2009-02-11
SK4362003A3 (en) 2003-08-05
PL207870B1 (pl) 2011-02-28
PE20020422A1 (es) 2002-06-28
HU226830B1 (en) 2009-11-30
DZ3478A1 (fr) 2002-04-18
SA01220412B1 (ar) 2006-11-05
CN1221549C (zh) 2005-10-05
EE200300171A (et) 2003-06-16
ES2228965T3 (es) 2005-04-16
CA2425539C (en) 2007-04-03
IS2339B (is) 2008-02-15
HK1086557A1 (zh) 2006-09-22
BG107687A (bg) 2003-09-30
JP2004526668A (ja) 2004-09-02
AP2003002775A0 (en) 2003-03-31
TR200402579T4 (tr) 2004-12-21
HUP0301022A2 (hu) 2003-10-28
KR100823860B1 (ko) 2008-04-21
HK1060567A1 (en) 2004-08-13
OA12403A (en) 2006-04-18
EA004381B1 (ru) 2004-04-29
NZ525733A (en) 2005-01-28
JP3764422B2 (ja) 2006-04-05
NO20031694L (no) 2003-04-11
BG66161B1 (bg) 2011-09-30
ATE276253T1 (de) 2004-10-15
CZ301841B6 (cs) 2010-07-07
HRP20030276B1 (en) 2006-02-28
WO2002030928A1 (de) 2002-04-18
EE04567B1 (et) 2005-12-15
AP1572A (en) 2006-02-13
RS50218B (sr) 2009-07-15
AU2002214996B2 (en) 2007-03-15
MY126931A (en) 2006-10-31
EP1468998A1 (de) 2004-10-20
YU27303A (sh) 2006-05-25
DE50103666D1 (de) 2004-10-21
UY26962A1 (es) 2002-06-20

Similar Documents

Publication Publication Date Title
MEP40008A (bs) Kristalni monohidrat, postupak za njegovo pripremanje i njegova primjena za pripremanje lijeka
MEP62008A (bs) Kristalni antiholinergik, postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka
MEP40608A (en) Method for producing the anticholinergic agent tiotropium bromide
MEP46708A (bs) Mikronizovani kristalni tiotropijum bromid
WO2002072095A3 (de) Tiotropiumsalzen zur behandlung von inflammatorischen erkrankungen
AU2002214996A1 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
YU2003A (sh) Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama
ES2159569T3 (es) Procedimiento de preparacion de derivados de sufentanil por adicion de carbeno y aminolisis de 4-piperidona.
YU186791A (sh) Nove farmaceutske formulacije koje sadrže farmaceutski aktivnu jonizujuću supstancu, kao i postupak za njihovo dobijanje
MEP47408A (en) Hfa-suspension formulations containing an anticholinergic
MEP47308A (en) Hfa-suspension formulation of an anhydrate
GEP20043300B (en) Amorphous Torasemide Modification
ECSP034921A (es) Anticolinérgico cristalino, metodo para su producción, y uso del mismo en la producción de una droga